Intravenous and Oral NOAEL Doses of the New PrC-210 Aminothiol in Swine and Dose Equivalency in Humans to Enable Clinical Trials

Written By Obvia

Link

Fahl WE, Fahl BL, Dingle AM.

Medicine in Drug Discovery

Obvia
Previous

A Defined Pathomechanism for Acute Radiation Syndrome Death and a Three Drug Regimen to Prevent It. International Journal of Molecular Sciences
Next

Significant suppression of Multiple Sclerosis inthe Mouse EAE Model Using the PrC-210 Aminothiol